SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > Tor DX in the news- Getting the word out before launch

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Jul 04, 2022 9:46am

185 Views

Post# 34798889

RE:Tor DX in the news- Getting the word out before launch

It's a nice DIRECT reference to SQI for a change. In the past the lung transplant story has always centered around the UHN and the Doc.

For better share demand creation, where are the Analysts and IR calls? I hear that Adelaide Capital does a pretty good job for it's clients. Then duplicate for the benefit of the US market.

MM

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing